ZOTA Zota Health Care Q3 FY26 results (Oct–Dec 2025) and concall
Zota Health Care reported robust top-line growth in Q3 FY26, with revenue nearly doubling and gross profit increasing over 113% YoY, driven by aggressive expansion of its Davaindia retail network. A successful INR 350 crore QIP provides capital for further growth. However, profitability metrics like EBITDA moderated due to front-loaded operating expenses and employee costs associated with a large pipeline of new stores, which management expects to normalize in the coming quarters.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q3 FY26: revenue up 59.8%, net profit up 188.9% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 |
|---|---|---|---|---|---|---|
| Revenue | 59 | 68 | 78 | 78 | 99 +68% | 109 +60% |
| EBITDA | 3 | 1 | 4 | 7 | 11 +233% | 8 +531% |
| Net profit | 2 | 2 | 3 | 6 | 10 +322% | 6 +189% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
